Cliff Asness's JANX Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 108,077 shares of Janux Therapeutics, Inc. (JANX) worth $1.66 M, representing 0.00% of the portfolio. First purchased in 2024-Q2, this short-term holding has been held for 6 quarters.
Based on 13F filings, Cliff Asness has maintained this position in JANX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 108,077 shares. Largest reduction occurred in Q2 2025, reducing 9,717 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Janux Therapeutics (JANX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Janux Therapeutics (JANX) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +108,077 | New Buy | 108,077 | $15.36 |
| Q2 2025 | -9,717 | Sold Out | 0 | $0.00 |
| Q1 2025 | +4,059 | Add 71.74% | 9,717 | $27.00 |
| Q4 2024 | +134 | Add 2.43% | 5,658 | $53.54 |
| Q3 2024 | +399 | Add 7.79% | 5,524 | $45.43 |
| Q2 2024 | +5,125 | New Buy | 5,125 | $41.89 |
Cliff Asness's Janux Therapeutics Investment FAQs
Cliff Asness first purchased Janux Therapeutics, Inc. (JANX) in Q2 2024, acquiring 5,125 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Janux Therapeutics, Inc. (JANX) for 6 quarters since Q2 2024.
Cliff Asness's largest addition to Janux Therapeutics, Inc. (JANX) was in Q2 2026, adding 108,077 shares worth $1.66 M.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 108,077 shares of Janux Therapeutics, Inc. (JANX), valued at approximately $1.66 M.
As of the Q2 2026 filing, Janux Therapeutics, Inc. (JANX) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Janux Therapeutics, Inc. (JANX) was 108,077 shares, as reported at the end of Q2 2026.